Oncology Views & Analysis

Views & Analysis

Oncology R&D: the patient insights we’re still missing, and ...

Imagine you are a pharma executive working in oncology R&D. The landscape is rapidly becoming more competitive and overcrowded.

Views & Analysis

Digital tools key to immuno-oncology’s future: report

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down.

Views & Analysis

Oncology and a year of COVID: lessons for the future

COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up opportunities to take learnings and create long-lasting change in research, pra

Views & Analysis

How hybrid virtual engagement is accelerating oncology commu...

COVID has revolutionised the way pharma engages with healthcare stakeholders – but to be truly successful, digital engagement needs to move away from an overreliance on real-time meetings,

Views & Analysis

Enabling healthcare’s digital future

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes

Views & Analysis

What HCPs think about health equity in cancer care

After more than a year of COVID-19 dominating health conversations, HCPs have been engaging in dialogue about continually evident disparities that many are facing in healthcare.

Oncology R&D: the patient insights we’re still missing, and ...

Digital tools key to immuno-oncology’s future: report

Oncology and a year of COVID: lessons for the future

How hybrid virtual engagement is accelerating oncology commu...

Enabling healthcare’s digital future

What HCPs think about health equity in cancer care

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks